Skip to main content
. 2017 Jun 29;2017(6):CD011412. doi: 10.1002/14651858.CD011412.pub2
Methods Randomised trial conducted in China
4 treatment arms: LEV, LTG, OXC and TPM
Participants Participants with newly diagnosed, complex partial epilepsy/complex partial secondary generalized seizures
Number randomised: LEV = 68, LTG = 70, OXC = 57, TPM = 58
Interventions Monotherapy with LEV, LTG, OXC or TPM
Doses started and achieved not stated
Outcomes "Effective rate" (assumed to be efficacy/seizure freedom)
One‐year retention rate
Cause of drug withdrawal
Notes Full text of the trial available only in Chinese (English abstract). Awaiting translation of the full text

Abbreviations: AED: antiepileptic drug; CBZ: carbamazepine; LEV: levetiracetam; LTG: lamotrigine; OXC: oxcarbazepine; PHT: phenytoin; TPM: topiramate; ZNS: zonisamide